The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

Author

  • Eugene Varfolomeev
  • John W Blankenship
  • Sarah M Wayson
  • Anna V Fedorova
  • Nobuhiko Kayagaki
  • Parie Garg
  • Kerry Zobel
  • Jasmin N Dynek
  • Linda O Elliott
  • Heidi J A Wallweber
  • Johan Flygare
  • Wayne J Fairbrother
  • Kurt Deshayes
  • V Dixit

Summary, in English

Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli. They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics. Herein, we demonstrate that small-molecule IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of auto-ubiquitination activity and rapid proteasomal degradation of c-IAPs. The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis. Additionally, the c-IAP proteins were found to function as regulators of NF-kappaB signaling. Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degradation of NIK, the central ser/thr kinase in the noncanonical NF-kappaB pathway.

Publishing year

2007

Language

English

Pages

669-669

Publication/Series

Cell

Volume

131

Issue

4

Document type

Journal article

Publisher

Cell Press

Topic

  • Hematology

Status

Published

ISBN/ISSN/Other

  • ISSN: 1097-4172